Companies Dominating the Throat Sprays Landscape
-
Cipla Limited
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Reckitt Benckiser Group PLC
- Procter & Gamble Company
- Prestige Consumer Healthcare Inc.
- Purdue Pharma L.P.
- Marinomed Biotech AG
- Biocidin Botanicals
- Melcare Biomedical Pty Ltd
- Ursatec GmbH
- Puressentiel UK Ltd
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of throat sprays is estimated at USD 543.6 million.
The throat sprays market size was valued at USD 511.2 million in 2024 and is likely to cross USD 840.61 million by 2037, expanding at more than 3.9% CAGR during the forecast period i.e., between 2025-2037. Rising level of air pollution, rise in prevalence of strep throat problem, upsurge in rhinitis, and spike in upper respiratory infections will drive the market growth.
North America industry is likely to hold largest revenue share of 30% by 2037, backed by presence of various major throat sprays manufacturers, a huge number of public awareness campaigns aimed at reducing infectious diseases, and growing population of elderly people in the region.
The major players in the market are Reckitt Benckiser Group PLC, Procter & Gamble Company, Prestige Consumer Healthcare Inc., Purdue Pharma L.P., Marinomed Biotech AG, Biocidin Botanicals, Melcare Biomedical Pty Ltd, Ursatec GmbH, Puressentiel UK Ltd